Financial Performance - Revenues for the three months ended March 31, 2022, increased by 1.2million,or432.867 million compared to 31.698millionforthesameperiodin2021[197].−Costofsalesroseby3.5 million, or 14%, for the three months ended March 31, 2022, totaling 27.696million,primarilydueto3.7 million from 2021 acquisitions and increased production costs[199]. - Gross margin decreased by 2.3million,or315.171 million, representing 16% of revenues for the three months ended March 31, 2022, down from 24% in the prior year[200]. - Selling, General and Administrative (SG&A) expenses surged by 9.7million,or8620.951 million, driven by equity-based compensation and litigation-related expenses[201]. - Research and development expenses increased by 0.7million,or731.724 million, reflecting a strategic investment in future technologies despite macroeconomic challenges[204]. - Net loss for the three months ended March 31, 2022, was 17.293million,comparedtoanetlossof7.674 million for the same period in 2021, marking a 125% increase in losses[197]. - Adjusted EBITDA for the three months ended March 31, 2022, was (4.669)million,adecreasefrom0.977 million for the same period in 2021[210]. Operational Highlights - The company completed multiple launches and successfully operated payloads on the International Space Station, demonstrating its commitment to supporting current space missions[187]. - The company is focused on expanding its infrastructure solutions to support the growth of the space economy, which is seen as being at an inflection point due to reduced launch costs[186]. - The company is investing in in-space manufacturing and assembly technologies, with a critical design review for OSAM-2 completed in Q4 2021[188]. - The company anticipates continued investment in technologies throughout 2022, despite the impact of COVID-19 and macroeconomic factors on its operations[189]. Financial Position - Available liquidity as of March 31, 2022, totaled 30.9million,consistingof5.9 million in cash and 25.0millioninavailableborrowings[225].−TotaldebtasofMarch31,2022,was77.867 million, a decrease from 79.204millionasofDecember31,2021[226].−Thecompanyhasidentifiedaplanforcostreductionactions,includingworkforcerationalizationsandbusinessunitoptimizationinitiatives[224].−Theconsolidatedtotalnetleverageratiowasamendedtonotexceed6.50:1.00asofthelastdayofanyquarter[229].−Therevolvingcreditfacilitycommitmentwasincreasedfrom5.0 million to 25.0milliononMarch25,2022[231].−AsofMarch31,2022,thecompanywasincompliancewithitsdebtcovenantsundertheAdamsStreetCreditAgreement[233].−Thecompanyenteredintoan80 million common stock purchase agreement to support growth strategies, including acquisitions and working capital[239]. Cash Flow and Investments - For the three months ended March 31, 2022, net cash used in operating activities was 11.4million,comparedto12.5 million for the same period in 2021[242][244]. - Net cash used in investing activities for the three months ended March 31, 2022, was 1.0million,significantlylowerthan34.1 million in the same period of 2021[245][246]. - For the three months ended March 31, 2022, net cash used in financing activities was 2.1million,comparedtoanetcashinflowof40.9 million in the same period of 2021[247]. - The company had total contractual obligations of 93.0millionasofMarch31,2022,includinglong−termdebtmaturitiesandfutureminimumleasepayments[240].−Thecompanyrepaidthefulloutstandingprincipalandinterestof41.6 million on the SVB Loan on September 2, 2021[236]. - The D&O Financing Loan of 3.0millionhasaninterestrateof1.7430.426 million compared to revenues of 32.867million[213].−ContractedbacklogattheendofMarch31,2022,was137.301 million, slightly down from 139.742millionattheendofDecember31,2021[218].−Totalbacklog,includingbothcontractedanduncontractedbacklog,was273.9 million as of March 31, 2022, with uncontracted backlog at $136.6 million[220].